Make remarkable happen

Transforming lives with pioneering ocular gene therapy

VISTA Trial

We are now pre-screening for a phase 2/3 clinical trial for X-Linked Retinitis Pigmentosa. Learn more about the clinical trial or how to qualify for no-cost genetic testing and/or prescreening.

We are an ophthalmic gene therapy company founded to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindness.

Bold science

AAV Gene Therapy

Gene therapy for ophthalmic disorders

Gene therapy is the process of modifying a patient’s cells by adding a functional copy of the mutated gene responsible for the disease. The new functional copy allows a patient’s own body to produce proteins to treat or prevent genetic conditions. A single treatment can provide long lasting benefits, potentially leading to a better quality of life.

Learn more
Blind man going down escalator next to child, both are smiling
close-up on a woman's blue eye seen in profile

Join us

Make Remarkable Happen

Beacon Therapeutics is always seeking new talent to join our teams and help deliver our mission to save and restore vision to patients with blinding retinal diseases.

If you are interested in joining our team and have the passion, skills and motivation to be a part of this transformational science, then we are keen to hear from you. Please refer to our careers information.

Explore careers
Researcher working in lab, mixing solutions
Man in lab coat working on computer